The TUDCA trial - innovative trial designs for amyotrophic lateral sclerosis drugs?

被引：5
作者：
Ludolph, A. C. [1 ]
机构：
[1] Univ Ulm, D-89069 Ulm, Germany
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2016年 / 23卷 / 01期
关键词：
DEXPRAMIPEXOLE;
D O I：
10.1111/ene.12691
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：11 / 12
页数：2
相关论文
共 7 条
[1]   The effects of dexpramipexole (KNS-760704) in individuals with amyotrophic lateral sclerosis [J].
Cudkowicz, Merit ;
Bozik, Michael E. ;
Ingersoll, Evan W. ;
Miller, Robert ;
Mitsumoto, Hiroshi ;
Shefner, Jeremy ;
Moore, Dan H. ;
Schoenfeld, David ;
Mather, James L. ;
Archibald, Donald ;
Sullivan, Mary ;
Amburgey, Craig ;
Moritz, Juliet ;
Gribkoff, Valentin K. .
NATURE MEDICINE, 2011, 17 (12) :1652-U169
[2]   Dexpramipexole versus placebo for patients with amyotrophic lateral sclerosis (EMPOWER): a randomised, double-blind, phase 3 trial [J].
Cudkowicz, Merit E. ;
van den Berg, Leonard H. ;
Shefner, Jeremy M. ;
Mitsumoto, Hiroshi ;
Mora, Jesus S. ;
Ludolph, Albert ;
Hardiman, Orla ;
Bozik, Michael E. ;
Ingersoll, Evan W. ;
Archibald, Donald ;
Meyers, Adam L. ;
Dong, Yingwen ;
Farwell, Wildon R. ;
Kerr, Douglas A. .
LANCET NEUROLOGY, 2013, 12 (11) :1059-1067
[3]   Targeted antioxidative and neuroprotective properties of the dopamine agonist pramipexole and its nondopaminergic enantiomer SND919CL2x [(+)2-amino-4,5,6,7-tetrahydro-6-L-propylamino-benzathiazole dihydrochloride] [J].
Danzeisen, R ;
Schwalenstoecker, B ;
Gillardon, F ;
Buerger, E ;
Krzykalla, V ;
Klinder, K ;
Schild, L ;
Hengerer, B ;
Ludolph, AC ;
Dorner-Ciossek, C ;
Kussmaul, L .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2006, 316 (01) :189-199
[4]   Tauroursodeoxycholic acid in the treatment of patients with amyotrophic lateral sclerosis [J].
Elia, A. E. ;
Lalli, S. ;
Monsurro, M. R. ;
Sagnelli, A. ;
Taiello, A. C. ;
Reggiori, B. ;
La Bella, V. ;
Tedeschi, G. ;
Albanese, A. .
EUROPEAN JOURNAL OF NEUROLOGY, 2016, 23 (01) :45-52
[5]   Dose-ranging study of riluzole in amyotrophic lateral sclerosis [J].
Lacomblez, L ;
Bensimon, G ;
Leigh, PN ;
Guillet, P ;
Meininger, V .
LANCET, 1996, 347 (9013) :1425-1431
[6]   Oral Solubilized Ursodeoxycholic Acid Therapy in Amyotrophic Lateral Sclerosis: A Randomized Cross-Over Trial [J].
Min, Ju-Hong ;
Hong, Yoon-Ho ;
Sung, Jung-Joon ;
Kim, Sung-Min ;
Lee, Jung Bok ;
Lee, Kwang-Woo .
JOURNAL OF KOREAN MEDICAL SCIENCE, 2012, 27 (02) :200-206
[7]   Dexpramipexole effects on functional decline and survival in subjects with amyotrophic lateral sclerosis in a Phase II study: Subgroup analysis of demographic and clinical characteristics [J].
Rudnicki, Stacy A. ;
Berry, James D. ;
Ingersoll, Evan ;
Archibald, Don ;
Cudkowicz, Merit E. ;
Kerr, Douglas A. ;
Dong, Yingwen .
AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION, 2013, 14 (01) :44-51
1